Pentobarbital will minimize the extent or effect of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. pentobarbital will decrease the extent or outcome of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a delicate CYP3A4 substrate. Coadministration with powerful or moderate CYP3A4 inducers is contraindicated. pent... https://dallasyhscn.blogerus.com/56661487/indicators-on-euthanasia-sodium-pentobarbital-you-should-know